# pathway_0061: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0061.txt)

**Task:** `pathway`  
**Author key, unchanged:** **D** — Secondary metabolite biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MAVVERDSDYYDSSYLADYYESLWTDHAALEDIAVYWAFFKERVLLSQSRVDSKFFLLDVGTGTGRVLHSLIDKAVNDADMSLDAMQFVGMDKSPFMLEQAQRAKQLPQEVRASWFVGTATALEDIASLADPHGKANLLIFAFSGINHLHQPGEIDQFFLSARRVLLPGGLALVSVCAPLLDIEGGDSVPNPYGQVKEVKSKRLEGILYREWETGQKIEGHLFTNSLKTDVVQVSQDGSERVIERNIHNIPLTLLTRDGLRRSAAAAKLEIIEERCIRDEVIFALRAVG

[Multiple Choices]
A. L-homoserine from L-aspartate: step 1/3. .
B. L-valine biosynthesis
C. L-isoleucine from 2-oxobutanoate: step 3/4. .
D. Secondary metabolite biosynthesis. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt entry for FrzE, annotated to secondary metabolite biosynthesis. The pathway annotation cites experimental evidence from a publication on FR901483 biosynthesis, supporting choice D.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence might support a general inference about enzyme class, but it does not establish which pathway this protein participates in; the amino-acid biosynthesis choices cannot be reliably distinguished from secondary metabolite biosynthesis using the supplied sequence alone.


**Missing item-specific fact**

> The protein-specific functional assignment that FrzE participates in FR901483 secondary-metabolite biosynthesis.


**Reason**

> That pathway assignment is supported by external, protein-specific functional evidence, not by a sufficiently discriminating biological argument supplied in the question.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The cited functional annotation supports D; the alternatives name different amino-acid biosynthesis steps.


### Important caveats

- The supporting UniProt record exactly matches the supplied sequence, but the reviewer-only accession and annotation were not provided to the evaluated model.
- The cited evidence supports the pathway assignment; the question itself does not supply that evidence.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence might support a general inference about enzyme class, but it does not establish which pathway this protein participates in; the amino-acid biosynthesis choices cannot be reliably distinguished from secondary metabolite biosynthesis using the supplied sequence alone.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific functional assignment that FrzE participates in FR901483 secondary-metabolite biosynthesis.",
    "reason": "That pathway assignment is supported by external, protein-specific functional evidence, not by a sufficiently discriminating biological argument supplied in the question."
  },
  "case_id": "pathway_0061",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for FrzE, annotated to secondary metabolite biosynthesis. The pathway annotation cites experimental evidence from a publication on FR901483 biosynthesis, supporting choice D."
  },
  "important_caveats": [
    "The supporting UniProt record exactly matches the supplied sequence, but the reviewer-only accession and annotation were not provided to the evaluated model.",
    "The cited evidence supports the pathway assignment; the question itself does not supply that evidence."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The cited functional annotation supports D; the alternatives name different amino-acid biosynthesis steps."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0061",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for FrzE, annotated to secondary metabolite biosynthesis. The pathway annotation cites experimental evidence from a publication on FR901483 biosynthesis, supporting choice D.",
    "evidence_ids": ["C1", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence might support a general inference about enzyme class, but it does not establish which pathway this protein participates in; the amino-acid biosynthesis choices cannot be reliably distinguished from secondary metabolite biosynthesis using the supplied sequence alone.",
    "missing_item_specific_fact": "The protein-specific functional assignment that FrzE participates in FR901483 secondary-metabolite biosynthesis.",
    "reason": "That pathway assignment is supported by external, protein-specific functional evidence, not by a sufficiently discriminating biological argument supplied in the question."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The cited functional annotation supports D; the alternatives name different amino-acid biosynthesis steps."
  },
  "important_caveats": [
    "The supporting UniProt record exactly matches the supplied sequence, but the reviewer-only accession and annotation were not provided to the evaluated model.",
    "The cited evidence supports the pathway assignment; the question itself does not supply that evidence."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A7T8F1L3 (FRZE_CLASX) annotates this 289-aa protein as N-methyltransferase FrzE, a member of the FR901483 biosynthesis cluster from Cladobotryum sp. The PATHWAY comment reads 'Secondary metabolite biosynthesis' with experimental evidence code ECO:0000269 from PubMed:33372776 (Zhang et al., JACS 2021). The benchmark sequence SHA256 matches the UniProt sequence exactly (sequence_version 1). The expected answer D is directly and experimentally supported.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a recognizable Rossmann-fold/methyltransferase motif (DVGTGTGRVLHSLID, a GxGxG pattern) characteristic of SAM-dependent methyltransferases. Options A (aspartate kinase step), B (valine biosynthesis enzymes: AHAS, ketol-acid reductoisomerase, dihydroxy-acid dehydratase, transaminase), and C (branched-chain aminotransferase step) all involve kinases, dehydrogenases, or transaminases—not methyltransferases. Methyltransferases are a hallmark tailoring enzyme class in secondary metabolite biosynthetic gene clusters. Thus, recognizing the methyltransferase fold and knowing that methyltransferases are absent from the specific amino-acid biosynthesis steps listed but common in secondary-metabolite tailoring provides a concrete reasoning path to D.


**Missing item-specific fact**

> None strictly required for elimination; however, confirming that this particular methyltransferase belongs to the FR901483 cluster (rather than a primary-metabolic methyltransferase) would require the specific database annotation. Among the four given options, the methyltransferase identity suffices to eliminate A, B, and C.


**Reason**

> A model with general knowledge of enzyme families in metabolic pathways can identify the GxGxG methyltransferase motif in the sequence, recognize that none of the amino-acid biosynthesis steps in options A–C employ methyltransferases, and conclude that D (secondary metabolite biosynthesis, where methyltransferase tailoring is ubiquitous) is the only compatible option. This constitutes a concrete biological argument from the supplied sequence and choices.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A, B, and C specify named enzymatic steps in well-characterized amino-acid biosynthesis pathways whose constituent enzymes are kinases, dehydrogenases, or transaminases. A methyltransferase sequence is incompatible with all three. Option D is the only pathway category among the choices that routinely includes methyltransferases. No ambiguity among the four options.


### Important caveats

- The reviewer-only UniProt annotation (experimental, ECO:0000269) confirms the key but was not available to the evaluated model; the model must rely on sequence-motif recognition and pathway-composition knowledge.
- The GxGxG motif identification from a raw 289-aa sequence is a non-trivial pattern-recognition step; a model may or may not extract it reliably.
- The specific identity of FR901483 biosynthesis (as opposed to other secondary-metabolite methyltransferases) is not derivable from sequence alone, but is not needed to select D among the given options.
- The UniProt entry was first publicly released 2025-06-18 (Swiss-Prot reviewed 2026-01-28); the author's source snapshot is unknown, but the sequence has been stable since 2021-06-02.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a recognizable Rossmann-fold/methyltransferase motif (DVGTGTGRVLHSLID, a GxGxG pattern) characteristic of SAM-dependent methyltransferases. Options A (aspartate kinase step), B (valine biosynthesis enzymes: AHAS, ketol-acid reductoisomerase, dihydroxy-acid dehydratase, transaminase), and C (branched-chain aminotransferase step) all involve kinases, dehydrogenases, or transaminases—not methyltransferases. Methyltransferases are a hallmark tailoring enzyme class in secondary metabolite biosynthetic gene clusters. Thus, recognizing the methyltransferase fold and knowing that methyltransferases are absent from the specific amino-acid biosynthesis steps listed but common in secondary-metabolite tailoring provides a concrete reasoning path to D.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None strictly required for elimination; however, confirming that this particular methyltransferase belongs to the FR901483 cluster (rather than a primary-metabolic methyltransferase) would require the specific database annotation. Among the four given options, the methyltransferase identity suffices to eliminate A, B, and C.",
    "reason": "A model with general knowledge of enzyme families in metabolic pathways can identify the GxGxG methyltransferase motif in the sequence, recognize that none of the amino-acid biosynthesis steps in options A–C employ methyltransferases, and conclude that D (secondary metabolite biosynthesis, where methyltransferase tailoring is ubiquitous) is the only compatible option. This constitutes a concrete biological argument from the supplied sequence and choices."
  },
  "case_id": "pathway_0061",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A7T8F1L3 (FRZE_CLASX) annotates this 289-aa protein as N-methyltransferase FrzE, a member of the FR901483 biosynthesis cluster from Cladobotryum sp. The PATHWAY comment reads 'Secondary metabolite biosynthesis' with experimental evidence code ECO:0000269 from PubMed:33372776 (Zhang et al., JACS 2021). The benchmark sequence SHA256 matches the UniProt sequence exactly (sequence_version 1). The expected answer D is directly and experimentally supported."
  },
  "important_caveats": [
    "The reviewer-only UniProt annotation (experimental, ECO:0000269) confirms the key but was not available to the evaluated model; the model must rely on sequence-motif recognition and pathway-composition knowledge.",
    "The GxGxG motif identification from a raw 289-aa sequence is a non-trivial pattern-recognition step; a model may or may not extract it reliably.",
    "The specific identity of FR901483 biosynthesis (as opposed to other secondary-metabolite methyltransferases) is not derivable from sequence alone, but is not needed to select D among the given options.",
    "The UniProt entry was first publicly released 2025-06-18 (Swiss-Prot reviewed 2026-01-28); the author's source snapshot is unknown, but the sequence has been stable since 2021-06-02."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and C specify named enzymatic steps in well-characterized amino-acid biosynthesis pathways whose constituent enzymes are kinases, dehydrogenases, or transaminases. A methyltransferase sequence is incompatible with all three. Option D is the only pathway category among the choices that routinely includes methyltransferases. No ambiguity among the four options."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0061",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A7T8F1L3 (FRZE_CLASX) annotates this 289-aa protein as N-methyltransferase FrzE, a member of the FR901483 biosynthesis cluster from Cladobotryum sp. The PATHWAY comment reads 'Secondary metabolite biosynthesis' with experimental evidence code ECO:0000269 from PubMed:33372776 (Zhang et al., JACS 2021). The benchmark sequence SHA256 matches the UniProt sequence exactly (sequence_version 1). The expected answer D is directly and experimentally supported.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a recognizable Rossmann-fold/methyltransferase motif (DVGTGTGRVLHSLID, a GxGxG pattern) characteristic of SAM-dependent methyltransferases. Options A (aspartate kinase step), B (valine biosynthesis enzymes: AHAS, ketol-acid reductoisomerase, dihydroxy-acid dehydratase, transaminase), and C (branched-chain aminotransferase step) all involve kinases, dehydrogenases, or transaminases—not methyltransferases. Methyltransferases are a hallmark tailoring enzyme class in secondary metabolite biosynthetic gene clusters. Thus, recognizing the methyltransferase fold and knowing that methyltransferases are absent from the specific amino-acid biosynthesis steps listed but common in secondary-metabolite tailoring provides a concrete reasoning path to D.",
    "missing_item_specific_fact": "None strictly required for elimination; however, confirming that this particular methyltransferase belongs to the FR901483 cluster (rather than a primary-metabolic methyltransferase) would require the specific database annotation. Among the four given options, the methyltransferase identity suffices to eliminate A, B, and C.",
    "reason": "A model with general knowledge of enzyme families in metabolic pathways can identify the GxGxG methyltransferase motif in the sequence, recognize that none of the amino-acid biosynthesis steps in options A–C employ methyltransferases, and conclude that D (secondary metabolite biosynthesis, where methyltransferase tailoring is ubiquitous) is the only compatible option. This constitutes a concrete biological argument from the supplied sequence and choices."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and C specify named enzymatic steps in well-characterized amino-acid biosynthesis pathways whose constituent enzymes are kinases, dehydrogenases, or transaminases. A methyltransferase sequence is incompatible with all three. Option D is the only pathway category among the choices that routinely includes methyltransferases. No ambiguity among the four options."
  },
  "important_caveats": [
    "The reviewer-only UniProt annotation (experimental, ECO:0000269) confirms the key but was not available to the evaluated model; the model must rely on sequence-motif recognition and pathway-composition knowledge.",
    "The GxGxG motif identification from a raw 289-aa sequence is a non-trivial pattern-recognition step; a model may or may not extract it reliably.",
    "The specific identity of FR901483 biosynthesis (as opposed to other secondary-metabolite methyltransferases) is not derivable from sequence alone, but is not needed to select D among the given options.",
    "The UniProt entry was first publicly released 2025-06-18 (Swiss-Prot reviewed 2026-01-28); the author's source snapshot is unknown, but the sequence has been stable since 2021-06-02."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record annotates the protein's pathway as secondary metabolite biosynthesis, citing experimental evidence (ECO:0000269). The record also identifies it as an N-methyltransferase. This supports the keyed choice, though the cited study was not independently reviewed here.

Citations as saved: [C5](#evidence-c5), [C4](#evidence-c4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence is 289 amino acids long and contains a glycine-rich segment around DVGTGTG, consistent with a possible SAM-dependent methyltransferase fold. A methyltransferase-like enzyme is a better fit for secondary-metabolite biosynthesis than the listed steps in homoserine, valine, or isoleucine biosynthesis, which are generally catalyzed by other enzyme families. This supports D probabilistically without identifying the exact protein.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The sequence feature and transferable enzyme-family knowledge provide a meaningful distinction among the offered choices. The inference is not a definitive family assignment from the sequence alone, but the choices do not require one.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> No other offered pathway is comparably supported by the sequence-level methyltransferase-like inference.


### Important caveats

- The sequence motif-based family inference is suggestive rather than conclusive.
- The reviewer-only database annotation supports the key but was not part of the original model input.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is 289 amino acids long and contains a glycine-rich segment around DVGTGTG, consistent with a possible SAM-dependent methyltransferase fold. A methyltransferase-like enzyme is a better fit for secondary-metabolite biosynthesis than the listed steps in homoserine, valine, or isoleucine biosynthesis, which are generally catalyzed by other enzyme families. This supports D probabilistically without identifying the exact protein.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The sequence feature and transferable enzyme-family knowledge provide a meaningful distinction among the offered choices. The inference is not a definitive family assignment from the sequence alone, but the choices do not require one."
  },
  "case_id": "pathway_0061",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C4"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates the protein's pathway as secondary metabolite biosynthesis, citing experimental evidence (ECO:0000269). The record also identifies it as an N-methyltransferase. This supports the keyed choice, though the cited study was not independently reviewed here."
  },
  "important_caveats": [
    "The sequence motif-based family inference is suggestive rather than conclusive.",
    "The reviewer-only database annotation supports the key but was not part of the original model input."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "No other offered pathway is comparably supported by the sequence-level methyltransferase-like inference."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0061",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates the protein's pathway as secondary metabolite biosynthesis, citing experimental evidence (ECO:0000269). The record also identifies it as an N-methyltransferase. This supports the keyed choice, though the cited study was not independently reviewed here.",
    "evidence_ids": ["C5", "C4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence is 289 amino acids long and contains a glycine-rich segment around DVGTGTG, consistent with a possible SAM-dependent methyltransferase fold. A methyltransferase-like enzyme is a better fit for secondary-metabolite biosynthesis than the listed steps in homoserine, valine, or isoleucine biosynthesis, which are generally catalyzed by other enzyme families. This supports D probabilistically without identifying the exact protein.",
    "missing_item_specific_fact": "",
    "reason": "The sequence feature and transferable enzyme-family knowledge provide a meaningful distinction among the offered choices. The inference is not a definitive family assignment from the sequence alone, but the choices do not require one."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "No other offered pathway is comparably supported by the sequence-level methyltransferase-like inference."
  },
  "important_caveats": [
    "The sequence motif-based family inference is suggestive rather than conclusive.",
    "The reviewer-only database annotation supports the key but was not part of the original model input."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry (A0A7T8F1L3) annotates this protein as N-methyltransferase FrzE (EC 2.1.1.-), a component of the FR901483 biosynthesis cluster, with pathway explicitly stated as 'Secondary metabolite biosynthesis' under evidence code ECO:0000269 (experimental, PubMed:33372776). The sequence matches exactly (289 AA, SHA256 match). This directly supports choice D.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The C-terminal region of the sequence (approximately residues 195-289) contains hallmark motifs of a Class I SAM-dependent methyltransferase fold: the 'REWI…GQ…GHLF…TNS…DGS…ERNI' pattern (specifically GILYREWETGQKIEGHLFTNSLKTDVVQVSQDGSERVIERNIHNIPLTLLTRDGLRRSAAAAKLEIIEERCIRDEVIFALRAVG). The N-terminal region also shows a classic Rossmann-fold NAD(P)-binding motif (DVGTGTGRVLHS, GxGxG pattern). A knowledgeable model can reason: (1) Methyltransferases are NOT components of standard amino acid biosynthesis pathways — aspartate kinase (A), valine biosynthesis enzymes (B, e.g., acetohydroxyacid synthase, dihydroxy-acid dehydratase), and isoleucine biosynthesis enzymes (C, e.g., branched-chain aminotransferase) use kinases, dehydratases, transaminases, and dehydrogenases, never SAM-dependent methyltransferases. (2) Methyltransferases are extremely common in secondary metabolite biosynthesis gene clusters, where methylation is a standard tailoring/modification step. (3) The dual-domain architecture (NAD(P)H-binding Rossmann fold + SAM methyltransferase) is a well-known configuration in secondary metabolite cluster enzymes. Therefore, the presence of a methyltransferase domain effectively rules out A, B, and C while pointing to D.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The methyltransferase fold is a well-recognized protein family identifiable from sequence motifs (GHLF, DGS, REWI patterns). The biochemical principle that standard amino acid biosynthesis (choices A, B, C) does not involve methyltransferases is general pathway knowledge. The association of methyltransferases with secondary metabolite tailoring is a widely established pattern across many natural product biosynthesis clusters. This constitutes a concrete, transferable inference from protein family recognition and pathway biochemistry that meaningfully distinguishes D from the amino acid biosynthesis distractors.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The methyltransferase domain clearly excludes standard amino acid biosynthesis pathways (A, B, C), which do not employ SAM-dependent methyltransferases. Only D (secondary metabolite biosynthesis) is consistent with the observed protein architecture.


### Important caveats

- The N-terminal Rossmann fold (DVGTGTGRVLHS) could superficially resemble NAD(P)-dependent reductases found in some amino acid pathways, but the C-terminal methyltransferase domain definitively excludes that interpretation.
- The reviewer-only evidence confirms experimental pathway assignment (ECO:0000269), but the evaluated model only had the sequence and choices; the reasoning relies on protein family recognition and general pathway biochemistry.
- FR901483 is a specific immunosuppressant secondary metabolite; the model need not know this specific compound, only the general principle that methyltransferases are hallmarks of secondary metabolite tailoring rather than primary amino acid biosynthesis.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The C-terminal region of the sequence (approximately residues 195-289) contains hallmark motifs of a Class I SAM-dependent methyltransferase fold: the 'REWI…GQ…GHLF…TNS…DGS…ERNI' pattern (specifically GILYREWETGQKIEGHLFTNSLKTDVVQVSQDGSERVIERNIHNIPLTLLTRDGLRRSAAAAKLEIIEERCIRDEVIFALRAVG). The N-terminal region also shows a classic Rossmann-fold NAD(P)-binding motif (DVGTGTGRVLHS, GxGxG pattern). A knowledgeable model can reason: (1) Methyltransferases are NOT components of standard amino acid biosynthesis pathways — aspartate kinase (A), valine biosynthesis enzymes (B, e.g., acetohydroxyacid synthase, dihydroxy-acid dehydratase), and isoleucine biosynthesis enzymes (C, e.g., branched-chain aminotransferase) use kinases, dehydratases, transaminases, and dehydrogenases, never SAM-dependent methyltransferases. (2) Methyltransferases are extremely common in secondary metabolite biosynthesis gene clusters, where methylation is a standard tailoring/modification step. (3) The dual-domain architecture (NAD(P)H-binding Rossmann fold + SAM methyltransferase) is a well-known configuration in secondary metabolite cluster enzymes. Therefore, the presence of a methyltransferase domain effectively rules out A, B, and C while pointing to D.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The methyltransferase fold is a well-recognized protein family identifiable from sequence motifs (GHLF, DGS, REWI patterns). The biochemical principle that standard amino acid biosynthesis (choices A, B, C) does not involve methyltransferases is general pathway knowledge. The association of methyltransferases with secondary metabolite tailoring is a widely established pattern across many natural product biosynthesis clusters. This constitutes a concrete, transferable inference from protein family recognition and pathway biochemistry that meaningfully distinguishes D from the amino acid biosynthesis distractors."
  },
  "case_id": "pathway_0061",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H1",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry (A0A7T8F1L3) annotates this protein as N-methyltransferase FrzE (EC 2.1.1.-), a component of the FR901483 biosynthesis cluster, with pathway explicitly stated as 'Secondary metabolite biosynthesis' under evidence code ECO:0000269 (experimental, PubMed:33372776). The sequence matches exactly (289 AA, SHA256 match). This directly supports choice D."
  },
  "important_caveats": [
    "The N-terminal Rossmann fold (DVGTGTGRVLHS) could superficially resemble NAD(P)-dependent reductases found in some amino acid pathways, but the C-terminal methyltransferase domain definitively excludes that interpretation.",
    "The reviewer-only evidence confirms experimental pathway assignment (ECO:0000269), but the evaluated model only had the sequence and choices; the reasoning relies on protein family recognition and general pathway biochemistry.",
    "FR901483 is a specific immunosuppressant secondary metabolite; the model need not know this specific compound, only the general principle that methyltransferases are hallmarks of secondary metabolite tailoring rather than primary amino acid biosynthesis."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The methyltransferase domain clearly excludes standard amino acid biosynthesis pathways (A, B, C), which do not employ SAM-dependent methyltransferases. Only D (secondary metabolite biosynthesis) is consistent with the observed protein architecture."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0061",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry (A0A7T8F1L3) annotates this protein as N-methyltransferase FrzE (EC 2.1.1.-), a component of the FR901483 biosynthesis cluster, with pathway explicitly stated as 'Secondary metabolite biosynthesis' under evidence code ECO:0000269 (experimental, PubMed:33372776). The sequence matches exactly (289 AA, SHA256 match). This directly supports choice D.",
    "evidence_ids": ["C4", "C5", "C6", "H1", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The C-terminal region of the sequence (approximately residues 195-289) contains hallmark motifs of a Class I SAM-dependent methyltransferase fold: the 'REWI…GQ…GHLF…TNS…DGS…ERNI' pattern (specifically GILYREWETGQKIEGHLFTNSLKTDVVQVSQDGSERVIERNIHNIPLTLLTRDGLRRSAAAAKLEIIEERCIRDEVIFALRAVG). The N-terminal region also shows a classic Rossmann-fold NAD(P)-binding motif (DVGTGTGRVLHS, GxGxG pattern). A knowledgeable model can reason: (1) Methyltransferases are NOT components of standard amino acid biosynthesis pathways — aspartate kinase (A), valine biosynthesis enzymes (B, e.g., acetohydroxyacid synthase, dihydroxy-acid dehydratase), and isoleucine biosynthesis enzymes (C, e.g., branched-chain aminotransferase) use kinases, dehydratases, transaminases, and dehydrogenases, never SAM-dependent methyltransferases. (2) Methyltransferases are extremely common in secondary metabolite biosynthesis gene clusters, where methylation is a standard tailoring/modification step. (3) The dual-domain architecture (NAD(P)H-binding Rossmann fold + SAM methyltransferase) is a well-known configuration in secondary metabolite cluster enzymes. Therefore, the presence of a methyltransferase domain effectively rules out A, B, and C while pointing to D.",
    "missing_item_specific_fact": "",
    "reason": "The methyltransferase fold is a well-recognized protein family identifiable from sequence motifs (GHLF, DGS, REWI patterns). The biochemical principle that standard amino acid biosynthesis (choices A, B, C) does not involve methyltransferases is general pathway knowledge. The association of methyltransferases with secondary metabolite tailoring is a widely established pattern across many natural product biosynthesis clusters. This constitutes a concrete, transferable inference from protein family recognition and pathway biochemistry that meaningfully distinguishes D from the amino acid biosynthesis distractors."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The methyltransferase domain clearly excludes standard amino acid biosynthesis pathways (A, B, C), which do not employ SAM-dependent methyltransferases. Only D (secondary metabolite biosynthesis) is consistent with the observed protein architecture."
  },
  "important_caveats": [
    "The N-terminal Rossmann fold (DVGTGTGRVLHS) could superficially resemble NAD(P)-dependent reductases found in some amino acid pathways, but the C-terminal methyltransferase domain definitively excludes that interpretation.",
    "The reviewer-only evidence confirms experimental pathway assignment (ECO:0000269), but the evaluated model only had the sequence and choices; the reasoning relies on protein family recognition and general pathway biochemistry.",
    "FR901483 is a specific immunosuppressant secondary metabolite; the model need not know this specific compound, only the general principle that methyltransferases are hallmarks of secondary metabolite tailoring rather than primary amino acid biosynthesis."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A7T8F1L3",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "ac16c3877a03a11f2374eb7829d8849eaaf1341f6b4a54416145c28c6bfae31d",
  "benchmark_sequence_length": 289,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 13,
    "firstPublicDate": "2025-06-18",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2021-06-02",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "8bf8f6b54a22924ce3e29b7871caafa0c559fc8abe3d986ff31d11379636d5a4",
  "current_source_sequence_sha256": "ac16c3877a03a11f2374eb7829d8849eaaf1341f6b4a54416145c28c6bfae31d",
  "current_source_sequence_length": 289,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 11,
  "selected_historical_version": {
    "accession": "A0A7T8F1L3",
    "database": "Swiss-Prot",
    "entryVersion": 11,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "FRZE_CLASX",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "02a95973abcefb95c240893b88e697665cd99234a9c35783731b0c3171f26890",
  "selected_historical_source_sequence_sha256": "ac16c3877a03a11f2374eb7829d8849eaaf1341f6b4a54416145c28c6bfae31d",
  "selected_historical_source_sequence_length": 289,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 11,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json",
  "source_sha256": "8bf8f6b54a22924ce3e29b7871caafa0c559fc8abe3d986ff31d11379636d5a4",
  "retrieved_utc": "2026-11-02T04:25:48.298817+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A7T8F1L3\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json",
  "source_sha256": "8bf8f6b54a22924ce3e29b7871caafa0c559fc8abe3d986ff31d11379636d5a4",
  "retrieved_utc": "2026-11-02T04:25:48.298817+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":13,\"firstPublicDate\":\"2025-06-18\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2021-06-02\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json",
  "source_sha256": "8bf8f6b54a22924ce3e29b7871caafa0c559fc8abe3d986ff31d11379636d5a4",
  "retrieved_utc": "2026-11-02T04:25:48.298817+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Sordariomycetes\",\"Hypocreomycetidae\",\"Hypocreales\",\"Hypocreaceae\",\"Cladobotryum\"],\"scientificName\":\"Cladobotryum sp\",\"taxonId\":2040732}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json",
  "source_sha256": "8bf8f6b54a22924ce3e29b7871caafa0c559fc8abe3d986ff31d11379636d5a4",
  "retrieved_utc": "2026-11-02T04:25:48.298817+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33372776\",\"source\":\"PubMed\"}],\"value\":\"FR901483 biosynthesis cluster protein E\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"33372776\",\"source\":\"PubMed\"}],\"value\":\"2.1.1.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33372776\",\"source\":\"PubMed\"}],\"value\":\"N-methyltransferase FrzE\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json",
  "source_sha256": "8bf8f6b54a22924ce3e29b7871caafa0c559fc8abe3d986ff31d11379636d5a4",
  "retrieved_utc": "2026-11-02T04:25:48.298817+00:00",
  "json_pointer": "/comments/3",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"33372776\",\"source\":\"PubMed\"}],\"value\":\"Secondary metabolite biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json",
  "source_sha256": "8bf8f6b54a22924ce3e29b7871caafa0c559fc8abe3d986ff31d11379636d5a4",
  "retrieved_utc": "2026-11-02T04:25:48.298817+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Zhang Z.\",\"Tamura Y.\",\"Tang M.\",\"Qiao T.\",\"Sato M.\",\"Otsu Y.\",\"Sasamura S.\",\"Taniguchi M.\",\"Watanabe K.\",\"Tang Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"33372776\"},{\"database\":\"DOI\",\"id\":\"10.1021/jacs.0c12352\"}],\"citationType\":\"journal article\",\"firstPage\":\"132\",\"id\":\"33372776\",\"journal\":\"J. Am. Chem. Soc.\",\"lastPage\":\"136\",\"publicationDate\":\"2021\",\"title\":\"Biosynthesis of the Immunosuppressant (-)-FR901483.\",\"volume\":\"143\"},\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"11231\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1L3?format=txt&versions=11)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A7T8F1L3?format=txt&versions=11",
  "source_sha256": "02a95973abcefb95c240893b88e697665cd99234a9c35783731b0c3171f26890",
  "retrieved_utc": "2026-11-02T04:25:50.153846+00:00",
  "source_locator": "lines 1-13",
  "excerpt": "ID   FRZE_CLASX              Reviewed;         289 AA.\nAC   A0A7T8F1L3;\nDT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.\nDT   02-JUN-2021, sequence version 1.\nDT   28-JAN-2026, entry version 11.\nDE   RecName: Full=N-methyltransferase FrzE {ECO:0000303|PubMed:33372776};\nDE            EC=2.1.1.- {ECO:0000269|PubMed:33372776};\nDE   AltName: Full=FR901483 biosynthesis cluster protein E {ECO:0000303|PubMed:33372776};\nGN   Name=FrzE {ECO:0000303|PubMed:33372776};\nOS   Cladobotryum sp.\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;\nOC   Hypocreomycetidae; Hypocreales; Hypocreaceae; Cladobotryum.\nOX   NCBI_TaxID=2040732;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 11,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1L3?format=txt&versions=11)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A7T8F1L3?format=txt&versions=11",
  "source_sha256": "02a95973abcefb95c240893b88e697665cd99234a9c35783731b0c3171f26890",
  "retrieved_utc": "2026-11-02T04:25:50.153846+00:00",
  "source_locator": "lines 14-22",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND\nRP   PATHWAY.\nRC   STRAIN=11231;\nRX   PubMed=33372776; DOI=10.1021/jacs.0c12352;\nRA   Zhang Z., Tamura Y., Tang M., Qiao T., Sato M., Otsu Y., Sasamura S.,\nRA   Taniguchi M., Watanabe K., Tang Y.;\nRT   \"Biosynthesis of the Immunosuppressant (-)-FR901483.\";\nRL   J. Am. Chem. Soc. 143:132-136(2021).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 11,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1L3?format=txt&versions=11)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A7T8F1L3?format=txt&versions=11",
  "source_sha256": "02a95973abcefb95c240893b88e697665cd99234a9c35783731b0c3171f26890",
  "retrieved_utc": "2026-11-02T04:25:50.153846+00:00",
  "source_locator": "lines 72-73",
  "excerpt": "CC   -!- PATHWAY: Secondary metabolite biosynthesis.\nCC       {ECO:0000269|PubMed:33372776}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 11,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 61. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
